Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01870518 · ClinicalTrials.gov registry record · NA
Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI
A NA study, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT01870518 is a NA study that was terminated before completion, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 13 participants.
The verdict
NCT01870518, a NA study, was terminated before completion, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
Purpose: This is a prospective single-center, randomized, patient and evaluator-blind clinical trial to compare the neurocognitive outcomes of globus pallidus interna (GPi) versus subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease (PD) patients with mild cognitive impairment (MCI).
Interventions
- DEVICE Bilateral GPi DBS
- DEVICE Bilateral STN DBS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01870518
The ClinicalTrials.gov registry entry for NCT01870518 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bilateral GPi DBS is the first listed.
NCT01870518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01870518 about?
NCT01870518 is a clinical study titled "Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI". Purpose: This is a prospective single-center, randomized, patient and evaluator-blind clinical trial to compare the neurocognitive outcomes of globus pallidus interna (GPi) versus subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson's disease (PD) patients with mild cognitive impairme...
What is the current status of trial NCT01870518?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2013-04. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01870518?
The interventions under investigation include: Bilateral GPi DBS (DEVICE), Bilateral STN DBS (DEVICE).
Who is sponsoring clinical trial NCT01870518?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.